Biomea Fusion, Inc. (BMEA) Financials
BMEA Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 225.1 million | 25.5 million |
2023-06-30 | 248.7 million | 24.4 million |
2023-03-31 | 112.6 million | 29.5 million |
2022-12-31 | 129.3 million | 20.8 million |
BMEA Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -23.9 million | 3.6 million |
2023-06-30 | -26.2 million | 3.4 million |
2023-03-31 | -27.0 million | 3.2 million |
2022-12-31 | -20.9 million | 2.7 million |
BMEA Net Income
No data available :(
BMEA Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 199.5 million | - | 12.1 million |
2023-06-30 | 223.3 million | - | 12.7 million |
2023-03-31 | 86.7 million | - | 13.3 million |
2022-12-31 | 113.4 million | - | 2.3 million |
BMEA Shares Outstanding
BMEA Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 39000 | 25.3 million | 5.8 million | - |
2023-06-30 | 417000 | 21.9 million | 5.7 million | - |
2023-03-31 | 2.9 million | 24.4 million | 5.6 million | - |
2022-12-31 | 712000 | 20.5 million | 5.7 million | - |
BMEA Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 1.1 million |
2023-06-30 | - | 1.1 million |
2023-03-31 | - | 905000 |
2022-12-31 | - | 326000 |
BMEA
Price: $12.35
52 week price:
Earnings Per Share: -3.44 USD
P/E Ratio: -6.17
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 55800
Market Capitalization: 465.8 million